Pemigatinib (Pemigatinib) market price per box and drug purchase cost reference instructions

Pemigatinib is a targeted drug mainly used to treat patients with cholangiocarcinoma and other solid tumors with FGFR2 gene rearrangements or fusions. It is already available in the domestic market in the form of pemetinib tablets, but it is not yet covered by medical insurance, so patients still have to pay for the medication out of their own pocket. The main specifications sold in China are 4.5mg14 tablets and 9mg14 tablets. The price per box ranges from 2 to 5 RMB. The price difference mainly depends on the tablet specifications and sales channels.

In overseas markets, the price of the original drug pemetinib is relatively higher. For example, the price of each box of 13.5mg*14 tablets of the original drug may reach more than 7 RMB, and the price may fluctuate due to exchange rates and import channels. The high prices make overseas purchases more costly for ordinary patients, so it is very important to choose medicine purchase methods through formal channels and under the guidance of professional doctors to ensure the authenticity and safety of the medicines.

In addition to the original drug, there are also generic versions of pemetinib available in overseas markets. The ingredients of these generic drugs are basically the same as the original drug, but the price is significantly lower. For example, the 4.5mg*14 tablets produced by Lucius Pharmaceuticals in Laos are sold for only about 700 yuan per box (the price may change slightly due to exchange rate fluctuations), providing a relatively economical option for domestic patients to obtain drugs through overseas channels.

Patients should comprehensively consider drug price, formal channels, safety, and legal and policy factors when purchasing drugs. In China, pemetinib can be obtained through some imported pharmacies or specific departments of hospitals, and a doctor's prescription is required. When purchasing generic drugs overseas, you should also ensure that the supplier is legal and reliable, and follow the doctor's guidance for dosage and course management. Reasonable selection of drug purchase channels and specifications can not only ensure the therapeutic effect, but also control the cost of treatment to a certain extent.

Keyword tag:

Pemetinib, dalbertam,FGFRinhibitors, cholangiocarcinoma, side effects, hyperphosphatemia, ocular side effects, adverse reactions, medication risks, targeted therapy

Reference materials:https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/213736s002lbl.pdf